Endocrine Testing Market Size, Share & Trends Report

Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (FSH, Insulin), By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: 978-1-68038-862-6
Number of Pages: 180
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Endocrine Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Estradiol (E2) Test
- Follicle Stimulating Hormone (FSH) Test
- Human Chorionic Gonadotropin (hCG) Hormone Test
- Luteinizing Hormone (LH) Test
- Dehydroepiandrosterone Sulfate (DHEAS) Test
- Progesterone Test
- Testosterone Test
- Thyroid Stimulating Hormone (TSH) Test
- Prolactin Test
- Cortisol Test
- Insulin Test
- Others
Endocrine Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Tandem Mass Spectrometry
- Immunoassay
- Monoclonal & Polyclonal Antibody Technologies
- Sensor Technology
- Clinical Chemistry
- Others
Endocrine Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Commercial Laboratories
- Ambulatory Care Centers
- Others
Endocrine Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Estradiol (E2) Test
    - Follicle Stimulating Hormone (FSH) Test
    - Human Chorionic Gonadotropin (hCG) Hormone Test
    - Luteinizing Hormone (LH) Test
    - Dehydroepiandrosterone Sulfate (DHEAS) Test
    - Progesterone Test
    - Testosterone Test
    - Thyroid Stimulating Hormone (TSH) Test
    - Prolactin Test
    - Cortisol Test
    - Insulin Test
    - Others
  - North America Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Immunoassay
    - Monoclonal & Polyclonal Antibody Technologies
    - Sensor Technology
    - Clinical Chemistry
    - Others
  - North America Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Commercial Laboratories
    - Ambulatory Care Centers
    - Others
  - U.S.
    - U.S. Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - U.S. Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - U.S. Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Canada
    - Canada Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Canada Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Canada Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
- Europe
  - Europe Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Estradiol (E2) Test
    - Follicle Stimulating Hormone (FSH) Test
    - Human Chorionic Gonadotropin (hCG) Hormone Test
    - Luteinizing Hormone (LH) Test
    - Dehydroepiandrosterone Sulfate (DHEAS) Test
    - Progesterone Test
    - Testosterone Test
    - Thyroid Stimulating Hormone (TSH) Test
    - Prolactin Test
    - Cortisol Test
    - Insulin Test
    - Others
  - Europe Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Immunoassay
    - Monoclonal & Polyclonal Antibody Technologies
    - Sensor Technology
    - Clinical Chemistry
    - Others
  - Europe Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Commercial Laboratories
    - Ambulatory Care Centers
    - Others
  - UK
    - UK Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - UK Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - UK Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Germany
    - Germany Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Germany Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Germany Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - France
    - France Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - France Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - France Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Italy
    - Italy Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Italy Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Italy Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Spain
    - Spain Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Spain Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Spain Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Sweden
    - Sweden Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Sweden Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Sweden Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Norway
    - Norway Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Norway Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Norway Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Denmark
    - Denmark Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Denmark Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Denmark Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
- Asia Pacific
  - Asia Pacific Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Estradiol (E2) Test
    - Follicle Stimulating Hormone (FSH) Test
    - Human Chorionic Gonadotropin (hCG) Hormone Test
    - Luteinizing Hormone (LH) Test
    - Dehydroepiandrosterone Sulfate (DHEAS) Test
    - Progesterone Test
    - Testosterone Test
    - Thyroid Stimulating Hormone (TSH) Test
    - Prolactin Test
    - Cortisol Test
    - Insulin Test
    - Others
  - Asia Pacific Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Immunoassay
    - Monoclonal & Polyclonal Antibody Technologies
    - Sensor Technology
    - Clinical Chemistry
    - Others
  - Asia Pacific Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Commercial Laboratories
    - Ambulatory Care Centers
    - Others
  - China
    - China Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - China Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - China Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Japan
    - Japan Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Japan Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Japan Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - India
    - India Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - India Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - India Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Australia
    - Australia Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Australia Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Australia Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Thailand
    - Thailand Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Thailand Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Thailand Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - South Korea
    - South Korea Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - South Korea Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - South Korea Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
- Latin America
  - Latin America Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Estradiol (E2) Test
    - Follicle Stimulating Hormone (FSH) Test
    - Human Chorionic Gonadotropin (hCG) Hormone Test
    - Luteinizing Hormone (LH) Test
    - Dehydroepiandrosterone Sulfate (DHEAS) Test
    - Progesterone Test
    - Testosterone Test
    - Thyroid Stimulating Hormone (TSH) Test
    - Prolactin Test
    - Cortisol Test
    - Insulin Test
    - Others
  - Latin America Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Immunoassay
    - Monoclonal & Polyclonal Antibody Technologies
    - Sensor Technology
    - Clinical Chemistry
    - Others
  - Latin America Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Commercial Laboratories
    - Ambulatory Care Centers
    - Others
  - Brazil
    - Brazil Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Brazil Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Brazil Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Mexico
    - Mexico Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Mexico Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Mexico Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Argentina
    - Argentina Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Argentina Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Argentina Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
- Middle East and Africa
  - Middle East and Africa Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Estradiol (E2) Test
    - Follicle Stimulating Hormone (FSH) Test
    - Human Chorionic Gonadotropin (hCG) Hormone Test
    - Luteinizing Hormone (LH) Test
    - Dehydroepiandrosterone Sulfate (DHEAS) Test
    - Progesterone Test
    - Testosterone Test
    - Thyroid Stimulating Hormone (TSH) Test
    - Prolactin Test
    - Cortisol Test
    - Insulin Test
    - Others
  - Middle East and Africa Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Tandem Mass Spectrometry
    - Immunoassay
    - Monoclonal & Polyclonal Antibody Technologies
    - Sensor Technology
    - Clinical Chemistry
    - Others
  - Middle East and Africa Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals
    - Commercial Laboratories
    - Ambulatory Care Centers
    - Others
  - Saudi Arabia
    - Saudi Arabia Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Saudi Arabia Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Saudi Arabia Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - South Africa
    - South Africa Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - South Africa Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - South Africa Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - UAE
    - UAE Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - UAE Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - UAE Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others
  - Kuwait
    - Kuwait Endocrine Testing Market, Test Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Estradiol (E2) Test
      - Follicle Stimulating Hormone (FSH) Test
      - Human Chorionic Gonadotropin (hCG) Hormone Test
      - Luteinizing Hormone (LH) Test
      - Dehydroepiandrosterone Sulfate (DHEAS) Test
      - Progesterone Test
      - Testosterone Test
      - Thyroid Stimulating Hormone (TSH) Test
      - Prolactin Test
      - Cortisol Test
      - Insulin Test
      - Others
    - Kuwait Endocrine Testing Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Tandem Mass Spectrometry
      - Immunoassay
      - Monoclonal & Polyclonal Antibody Technologies
      - Sensor Technology
      - Clinical Chemistry
      - Others
    - Kuwait Endocrine Testing Market, End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals
      - Commercial Laboratories
      - Ambulatory Care Centers
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.